COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Etonogestrel Implant as Emergency Contraception

Phase 4

Recruiting

Conditions: Contraception

Interventions: Drug: Etonogestrel implant

First Posted Date: 2022-02-11

Last Posted Date: 2023-04-20

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 12

Registration Number: NCT05237141

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Radiotherapy in Combo With Chemo and Immunotherapy in Patients With PD-L1 Positive Metastatic TNBC

Phase 2

Withdrawn

Conditions: Unresectable Breast Carcinoma
Locally Advanced Breast Cancer
Metastatic Breast Cancer
PD-L1 Gene Mutation
Triple Negative Breast Cancer

Interventions: Drug: Nab-paclitaxel
Drug: Paclitaxel
Radiation: Radiation Therapy
Drug: Pembrolizumab

First Posted Date: 2022-02-10

Last Posted Date: 2022-12-06

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT05233696

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States

A Focus Group Study to Explore Smoking Triggers and Acceptability of Just-in-time Adaptive Intervent

Active, not recruiting

Conditions: Smoking
Smoking Behaviors
Smoking Cessation

Interventions: Behavioral: Focus Group

First Posted Date: 2022-02-09

Last Posted Date: 2024-02-05

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 2

Registration Number: NCT05231421

Locations: 🇺🇸
Colorado Research Center, Aurora, Colorado, United States

Better Together Physician Coaching: An Innovative Solution to Medical Trainee Burnout

Not Applicable

Completed

Conditions: Burnout, Professional

Interventions: Behavioral: Better Together Physician Coaching

First Posted Date: 2022-02-03

Last Posted Date: 2023-09-28

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 1017

Registration Number: NCT05222685

Locations: 🇺🇸
University of Colorado, Aurora, Colorado, United States

Advanced Planning for Online Accounts and Data

Not Applicable

Recruiting

Conditions: Terminal Cancer
Metastatic Cancer

Interventions: Other: Post-Mortem Plan

First Posted Date: 2022-02-03

Last Posted Date: 2024-03-15

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 300

Registration Number: NCT05222308

Locations: 🇺🇸
University of Colorado Health, Aurora, Colorado, United States

CNS Qualitative Interview

Recruiting

Conditions: Central Nervous System Cancer

Interventions: Behavioral: Qualitative Interviews

First Posted Date: 2022-02-01

Last Posted Date: 2024-10-28

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 20

Registration Number: NCT05219149

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

Transverse Abdominus Plane Block Study

Phase 2

Withdrawn

Conditions: Surgery
Colorectal Disorders

Interventions: Combination Product: Ropivacaine, Dexmedetomidine, Dexamethasone sodium phosphate, Normal saline
Drug: Liposomal bupivacaine

First Posted Date: 2022-01-31

Last Posted Date: 2023-03-06

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT05216055

Critical Windows in the Development of Asthma Endotypes and Phenotypes in High-Risk Toddlers

Active, not recruiting

Conditions: Asthma in Children
Wheezing

First Posted Date: 2022-01-27

Last Posted Date: 2024-01-16

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 192

Registration Number: NCT05210361

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

Testing Messages to Promote HPV Vaccination

Not Applicable

Completed

Conditions: Intention
Vaccine Hesitancy
Behavior, Information Seeking

Interventions: Behavioral: Health Messages

First Posted Date: 2022-01-25

Last Posted Date: 2022-01-25

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 784

Registration Number: NCT05206669

68Ga-PSMA-11 PET in Patients With Prostate Cancer

Phase 3

Completed

Conditions: Prostate Adenocarcinoma
Prostate Cancer

Interventions: Drug: Ga-PSMA-11

First Posted Date: 2022-01-19

Last Posted Date: 2023-11-13

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 39

Registration Number: NCT05197257

Locations: 🇺🇸
Colorado Research Center, Aurora, Colorado, United States
🇺🇸
UCHealth-Metro Denver, Denver, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy